Osprey Medical, Inc. – Trademark Portfolio
Entity Type: 03
Osprey Medical, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 8 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DYEVERT and DYEMINISH. The owner is based in Minnetonka, MN.
5600 Rowland Road, Suite 250
Minnetonka, MN 55343
Showing of trademarks Trademarks
Trademark Classifications
Osprey Medical, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Osprey Medical, Inc. have?
Osprey Medical, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned, 5 cancelled.
What trademark classes does Osprey Medical, Inc. file in?
Osprey Medical, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 16 (Paper Goods), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Osprey Medical, Inc.'s most well-known trademarks?
Osprey Medical, Inc.'s registered trademark portfolio includes well-known marks such as DYEVERT and DYEMINISH. These are among 2 currently registered trademarks in the portfolio.
What is Osprey Medical, Inc.'s trademark registration success rate?
Osprey Medical, Inc. has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.